Related Experiment Video
Updated: Jan 28, 2026

Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
Successful Bridge to Transplant in a Pediatric Patient Using the SynCardia 50 cc Total Artificial Heart
Gary S Beasley1, Kiona Allen2, Elfride Pahl2
1From the Le Bonheur Children's Hospital, University of Tennessee Health Science Center, Division of Pediatric Cardiology Memphis, Tennessee.
Insights
Pediatric heart transplant wait-list mortality is high. This study details the successful use of the smallest artificial heart device (50 cc SynCardia) in a pediatric patient, supporting them for 278 days before transplant.
Area of Science:
- Pediatric cardiology
- Mechanical circulatory support
- Cardiac surgery
Background:
- Pediatric heart transplant candidates face high wait-list mortality.
- Mechanical circulatory support (MCS) improves survival for patients awaiting heart transplantation.
- Biventricular MCS presents unique challenges in pediatric patients.
Observation:
- A pediatric patient with a body surface area of 0.9 m² was supported with a 50 cc SynCardia Total Artificial Heart.
- This represents the smallest patient to date to receive this specific device.
- The patient was successfully supported for 278 days.
Findings:
- The 50 cc SynCardia Total Artificial Heart provided effective mechanical circulatory support in a very small pediatric patient.
- Sustained support was achieved for an extended period (278 days).
- The patient ultimately underwent a successful heart transplant.
Implications:
- This case demonstrates the feasibility of using the 50 cc SynCardia Total Artificial Heart in extremely small pediatric patients.
- It offers a potential bridge to transplant for critically ill pediatric heart failure patients.
- Further research into biventricular MCS in pediatrics is warranted.
Abstract:
Pediatric heart transplant candidates have the highest wait-list mortality of all organ candidates. Mechanical circulatory support has improved survival for many patients awaiting transplant. Biventricular mechanical circulatory support remains a particular challenge for pediatric patients. We present the smallest patient (body surface area 0.9 m) to date to receive the 50 cc SynCardia Total Artificial Heart, supported for 278 days before successful heart transplant.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Ecological Succession
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Design Example: Strain Gauge Bridge or Wheatstone Bridge

